MELBOURNE, Fla., June 27,
2024 /PRNewswire/ -- The Preeclampsia Foundation
is seeking Letters of Intent for the Peter Joseph Pappas Research
Grants funding program, designed to accelerate preeclampsia
research. The ultimate goal of this grant program is to drive
research that will eliminate the delivery of pre-term babies as an
intervention for severe preeclampsia, HELLP syndrome, and related
hypertensive disorders of pregnancy. Named for the infant son of
preeclampsia survivor Lauren Pappas
and her husband Clement, the program seeks to award multiple
two-year grants in 2025 totaling up to $200,000.
Eligible applicants should focus on the current research gaps
identified through a 2020 preeclampsia workshop jointly sponsored
by the Preeclampsia Foundation and the Society for Maternal Fetal
Medicine. Examples of such proposals include, but are not limited
to, understanding pathophysiological pathways and subtypes of
preeclampsia, mechanisms for improved diagnosis or prediction,
therapeutic interventions to halt, reverse, or prevent the
placental and organ dysfunction associated with the condition, and
supporting preconception and inter-conception health to improve
perinatal outcomes. In addition to meeting the fund's research
criteria, preference will be given to proposals that use or build
upon data available through the Preeclampsia Registry™
(self-reported, whole exome sequenced, and clinical data), or that
will produce data or biological materials that can be added to the
Registry. All criteria are outlined in the application
instructions, available at
www.preeclampsia.org/research-funding.
The grant is named after the son of Lauren and Clement Pappas, who was delivered at
29-weeks due to severe preeclampsia and HELLP syndrome. The program
has funded almost a dozen studies, including innovative research
into potential therapeutics, genetic markers, and the role of
placental functioning in preeclampsia's development.
"We lost our son Peter due to preeclampsia following a 29-week
delivery," explained Lauren Pappas.
"Since then, we have dedicated our lives to helping others avoid
the same outcome by establishing the Peter Joseph Pappas Fund."
"Thanks to generous contributions from family and friends, and
our partnership with the Preeclampsia Foundation, we are making
strides to reach our ultimate goal of eliminating pre-term births
due to preeclampsia by 2050," added Clement
Pappas.
The Peter Joseph Pappas Research Grants program adds to the
Preeclampsia Foundation's portfolio of research programs including
the Vision Grant program for young investigators, and the
Preeclampsia Registry, a dynamic database of research participants
including preeclampsia and HELLP syndrome survivors, family
members, and controls (unaffected individuals).
Complete details can be found online
at www.preeclampsia.org/research-funding. Letters of intent
are due by Friday, August 30, 2024
via email to PJPGrants@preeclampsia.org.
About the Preeclampsia Foundation
The Preeclampsia Foundation is a U.S.-based 501(c)(3) non-profit
organization established in 2000 to improve the outcomes of
hypertensive disorders of pregnancy by educating, supporting, and
engaging the community, improving healthcare practices, and finding
a cure. We envision a world where preeclampsia and related
hypertensive disorders of pregnancy no longer threaten the lives of
mothers and babies. For more information,
visit www.preeclampsia.org.
About the Peter Joseph Pappas Research Grant
Program
Clement and Lauren
Pappas of Philadelphia, PA,
lost their firstborn child, Peter
Joseph, after HELLP syndrome necessitated his early
delivery. Their son, born at 29 weeks' gestation, spent a week in
the neonatal intensive care unit before dying from a central line
infection. The Pappas family, along with friends and family, have
established this special fund with the Preeclampsia Foundation to
advance research, with the overarching goal of eliminating pre-term
births due to preeclampsia by 2050.
Contact: Laney Poye
Director of Communications and Engagement
321.421.6957
379706@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/new-scientific-research-funding-available-to-eliminate-pre-term-deliveries-from-preeclampsia-302183345.html
SOURCE Preeclampsia Foundation